| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |